✦ LIBER ✦

The Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Reverses the Invasive Phenotype of Her-2/neu-Driven Breast Cancer

✍ Scribed by Min, C.; Kirsch, K. H.; Zhao, Y.; Jeay, S.; Palamakumbura, A. H.; Trackman, P. C.; Sonenshein, G. E.

Book ID: 118199627
Publisher: American Association for Cancer Research
Year: 2007
Tongue: English
Weight: 464 KB
Volume: 67
Category: Article
ISSN: 0008-5472
DOI: 10.1158/0008-5472.can-06-3867

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Repression of BCL2 by the Tumor Suppress

Repression of BCL2 by the Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Inhibits Transformed Phenotype of Lung and Pancreatic Cancer Cells

✍ Wu, M.; Min, C.; Wang, X.; Yu, Z.; Kirsch, K. H.; Trackman, P. C.; Sonenshein, G 📂 Article 📅 2007 🏛 American Association for Cancer Research 🌐 English ⚖ 388 KB

The tumor suppression activity of E1A in

The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer

✍ Chang, Joe Yujiao; Xia, Weiya; Shao, Ruping; Sorgi, Frank; Hortobagyi, Gabriel N 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 657 KB

P31 Does HER2/neu expression on the prim

P31 Does HER2/neu expression on the primary tumor of breast cancer patients predict the phenotype of minimal residual disease?

✍ B. Rack; A. Schoberth; W. Janni; S. Schulze; C. Schindlbeck; M. Heinrigs; B. Str 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 300 KB

HER-2/neu status and tumor morphology of

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

✍ Louise A. Quenneville; Kelly-Anne Phillips; Hilmi Ozcelik; Robert K. Parkes; Jul 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Abstract ## BACKGROUND The prevalence of BRCA1 germline mutations is greater in the Ashkenazi Jewish population than in the general North American population. The Ontario Familial Breast Cancer Registry collects clinical and family history data in familial breast carcinoma cases, and unselected